Home
About
Why DFCR?
Strategic Vision
Platform of Regulations
Leadership
DFCR Experts
DFCR Updates
Advocacy
Media
Expert Testimony
Coalition Partners
Education
Regulation & Public Health
Harms of Prohibition
Myths, Risks & Uncertainties
Ask a Question
Regulation
Universal Cannabis Symbol
JOIN
DONATE
Home
Categories
Expert Testimony
Expert Testimony
Expert Testimony
DFCR Letter to the House in Strong Support of the MORE Act
DFCR
2/24/22
Expert Testimony
Delaware House Health and Human Development Committee HB 305
David L. Nathan, MD, DFAPA
1/26/22
Expert Testimony
DFCR Letter to the House in Support of the MORE Act
DFCR
10/1/21
Expert Testimony
New Jersey Cannabis Regulatory Commission: High potency THC, Edibles
Mikhail Kogan, MD, ABOIM
6/2/21
Expert Testimony
Colorado House Public & Behavioral Health & Human Services HB21-1317
Bryon Adinoff, MD
5/18/21
Expert Testimony
Alabama House SB46
Bryon Adinoff, MD
4/26/21
Expert Testimony
Texas House Criminal Jurisprudence Committee HB3772
Bryon Adinoff, MD
4/20/21
Expert Testimony
Delaware House Human Health Committee HB150
David L. Nathan, MD, DFAPA
3/24/21
Expert Testimony
Delaware House Human Health Committee HB150
Bryon Adinoff, MD
3/24/21
Expert Testimony
Connecticut General Assembly Judiciary SB888
Hugh Blumenfeld, MD, PhD
3/1/21
Expert Testimony
Connecticut General Assembly Judiciary SB888
Bryon Adinoff, MD
2/25/21
Expert Testimony
New York Legislature CRTA
Tanya Adams, DO
2/23/21
Expert Testimony
New Jersey Senate Judiciary AB1898
David L. Nathan, MD, DFAPA
2/22/21
Expert Testimony
Virginia Senate: Adult Use Cannabis
Bryon Adinoff, MD
1/31/21
Expert Testimony
Comments in Response to the Cannabis Administration and Opportunity Act (CAOA)
DFCR
1/1/21
Expert Testimony
US Senate Cannabis Administration and Opportunity Act
Marijuana Justice Coalition
1/1/21
Expert Testimony
New Jersey Assembly Appropriations: Regulations
David L. Nathan, MD, DFAPA
11/20/20
Expert Testimony
New Jersey Assembly Oversight, Reform and Federal Relations
David L. Nathan, MD, DFAPA
11/10/20
Expert Testimony
Connecticut Senate Judiciary SB16
Bryon Adinoff, MD
3/3/20
Expert Testimony
Connecticut Senate Judiciary SB16
David L. Nathan, MD, DFAPA
3/3/20
Expert Testimony
US House Subcommittee Cannabis Policies for the New Decade
David L. Nathan, MD, DFAPA
1/18/20
Expert Testimony
Alabama House SB165
Donald O. Lyman, MD, DTPH
1/1/20
Expert Testimony
Alabama House SB165
Genester Wilson-King, MD, FACOG
1/1/20
Expert Testimony
Alabama House SB165
Wendy Askew, MD
1/1/20
Expert Testimony
New Jersey General Assembly CR840
Monica Taing, PharmD
12/12/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Bryon Adinoff, MD
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Genester Wilson-King, MD, FACOG
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Donald O. Lyman, MD, DTPH
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Rachel Knox, MD
10/23/19
Expert Testimony
Kansas Senate Federal and State Affairs SB366
Wendy Askew, MD
10/23/19
Expert Testimony
U.S. House: Congressional Committee Hearing on Cannabis Legalization
David L. Nathan, MD, DFAPA
7/10/19
Expert Testimony
Delaware House Revenue & Finance HB110
Bryon Adinoff, MD
6/5/19
Expert Testimony
Colorado Senate Medical Marijuana Code SB218
Bryon Adinoff, MD
5/10/19
Expert Testimony
Vermont House Government Operations SB54
David L. Nathan, MD, DFAPA
4/30/19
Expert Testimony
South Carolina Medical Affairs S.366
Bryon Adinoff, MD
4/6/19
Expert Testimony
South Carolina Medical Affairs S.366
Julia Arnsten, MD, MPH
4/1/19
Expert Testimony
New Jersey Senate Judiciary SB2703
David L. Nathan, MD, DFAPA
3/19/19
Expert Testimony
Texas House Public Health HB1365
Bryon Adinoff, MD
3/16/19
Expert Testimony
Texas House Criminal Jurisprudence HB63
Bryon Adinoff, MD
3/4/19
Expert Testimony
Vermont Senate Judiciary SB54
David L. Nathan, MD, DFAPA
2/1/19
Expert Testimony
New York General Assembly
Julia Arnsten, MD, MPH
12/1/18
Expert Testimony
New Jersey Senate Judiciary SB2703
Monica Taing, PharmD
11/1/18
Expert Testimony
New York Assembly Codes, Health, Governmental Operations, Alcoholism and Drug Abuse
David L. Nathan, MD, DFAPA
10/17/18
Expert Testimony
Connecticut Commission on Women, Children and Seniors Cannabis Forum (Video)
David L. Nathan, MD, DFAPA
4/30/18
Expert Testimony
New Jersey Division of Consumer Affairs Marijuana Reclassification
David L. Nathan, MD, DFAPA
4/25/18
Expert Testimony
U.S. FDA Cannabis Scheduling
David L. Nathan, MD, DFAPA
4/23/18
Expert Testimony
New Jersey Assembly Oversight, Reform and Federal Relations Committee on Cannabis Legalization
David L. Nathan, MD, DFAPA
3/6/18
Expert Testimony
Illinois General Assembly SB316
David L. Nathan, MD, DFAPA
1/23/18
Expert Testimony
Testimony before the Illinois Senate on Marijuana Legalization
Leslie Mendoza Temple, MD, ABOIM
1/22/18
Expert Testimony
New Jersey Senate Judiciary Cannabis Adult Use
David L. Nathan, MD, DFAPA
6/19/17
Expert Testimony
Delaware House Revenue & Finance HB110
David L. Nathan, MD, DFAPA
5/11/17
Expert Testimony
Texas House Criminal Jurisprudence HB2107
Bryon Adinoff, MD
5/3/17
Expert Testimony
California State Assembly AB1606
DFCR
4/14/17
Expert Testimony
Vermont House Human Services H.170
Bryon Adinoff, MD
4/12/17
Expert Testimony
Rhode Island House Judiciary HB5555
David L. Nathan, MD, DFAPA
4/12/17
Expert Testimony
Texas House Criminal Jurisprudence HB81
Bryon Adinoff, MD
3/14/17
Expert Testimony
New Jersey Senate Judiciary
David L. Nathan, MD, DFAPA
11/17/15
Categories
Expert Testimony
DFCR Updates
Media
Education
Browse by Location
Alabama
California
Colorodo
Connecticut
Delaware
Federal
Illinois
International
Kansas
Montana
New Jersey
New York
Pennsylvania
Rhode Island
South Carolina
Texas
Vermont
Virginia